The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology

Area of Science:

• Immunology
• Cardiovascular Medicine
• Pathophysiology

Background:

• Chronic inflammation and tissue damage are central to acquired cardiovascular diseases (CVD).
• Both innate and adaptive immunity contribute to inflammation in CVD, but mechanisms in human disease are not fully defined.
• Autoantibodies (AAbs), including induced and natural antibodies, are present in various human CVDs and shown to modulate disease progression in experimental models.

Purpose of the Study:

• To review and critically assess the current understanding of autoantibody (AAb) function in cardiovascular diseases (CVD).
• To evaluate the clinical and experimental evidence regarding the role of AAbs in CVD pathogenesis.
• To highlight challenges in translating animal model findings to human CVD and identify key unanswered questions.

Main Methods:

• Critical review of existing clinical and experimental literature on autoantibodies in cardiovascular disease.
• Assessment of studies investigating both induced and natural autoantibodies.
• Analysis of evidence from various CVD models, including atherosclerosis, dilated cardiomyopathy, and valvular heart disease.

Main Results:

• Autoantibodies (AAbs) are implicated in modulating the natural history of multiple cardiovascular diseases (CVD).
• There is a lack of consensus on the specific functions of AAbs in CVD, with conflicting conclusions from different studies.
• Significant challenges exist in translating findings from animal models to human CVD physiology and disease.

Conclusions:

• The precise roles of autoantibodies (AAbs) in human cardiovascular diseases (CVD) require further elucidation.
• Resolving discrepancies in experimental findings and addressing the translatability of animal models are critical for future research.
• Understanding AAb function is essential for advancing therapeutic strategies for inflammatory cardiovascular conditions.